BAKER BIOTECH CAPITAL GP LLC 4
4 · SEATTLE GENETICS INC /WA · Filed Mar 30, 2005
Insider Transaction Report
Form 4
Baker Biotech Capital (GP), LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2005-03-29$4.90/sh+6,605$32,359→ 279,963 total(indirect: See Footnote) - Purchase
Common Stock
2005-03-28$4.90/sh+901$4,415→ 270,591 total(indirect: See Footnote) - Purchase
Common Stock
2005-03-29$4.81/sh+2,767$13,320→ 273,358 total(indirect: See Footnote)
Footnotes (3)
- [F1]In addition to Baker Biotech Capital (GP), LLC, this Form 4 is being filed jointly by Julian C. Baker and Felix J. Baker, each of whom has the same business address as Baker Biotech Capital (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Because of certain relationships with other security holders of the Issuer, the Reporting Persons have filed on Schedule 13D as if they were a member of a group of such shareholders. (Continued in footnote 2.)
- [F2]However, the Reporting Persons disclaim that they and any other person or persons, including those persons with whom the Reporting Persons have filed a Schedule 13D, in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein. Felix J. Baker is a director of the Issuer.
- [F3]Represents shares of common stock owned directly by Baker Biotech Fund I, L.P., the sole general partner of which is Baker Biotech Capital, L.P., a limited partnership the sole general partner of which is Baker Biotech Capital (GP), LLC. Felix J. Baker and Julian C. Baker are the controlling members of Baker Biotech Capital (GP), LLC.